Scientist Jailed for Gene Hacking Babies Says Ethics Are Holding Back Progress
By Luis Prada,
Vice
| 03. 14. 2025
public domain photo by Voice of America via Wikimedia Commons
Back in 2019, Chinese biophysicist He Jiankui proudly announced to the world that he had created two genetically edited human babies, fully expecting a round of applause and three cheers of “Hip Hip Hooray.” Instead, everyone booed him and he got thrown in prison for three years.
He’s since been released from prison, though it doesn’t seem like he’s learned any lessons from his stint in the clink. This was demonstrated by a post on Twitter/X wherein he accompanied a soulless picture of himself in a tweet in which he says that “ethics is holding back scientific innovation and progress.”
Now, you might recognize that is the kind of thing a villain says before he splices into your DNA, unforeseen consequences be damned. Jiankui used CRISPR gene-editing technology to edit the DNA of a set of twins codenamed “Nana” and “Lulu” to make them immune to HIV. Sounds like a noble goal, until you find out that fiddling with those genes to make the girls immune to HIV could...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...